AG
REGN icon

AmeriFlex Group’s Regeneron Pharmaceuticals REGN Stock Holding History

AmeriFlex Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.5K Sell
113
-48
-30% -$32.7K 0.03% 413
2026
Q1 		$124K Buy
161
+16
+11% +$12.2K 0.06% 239
2025
Q4 		$112K Buy
+145
New +$98.5K 0.06% 254
2025
Q2 		– Sell
-175
Closed -$111K – 1243
2025
Q1 		$111K Buy
+175
New +$120K 0.05% 324

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AmeriFlex Group's REGN Position: Q2 2026 in Review

AmeriFlex Group reduced its Regeneron Pharmaceuticals (REGN) stake by 30% in Q2 2026, selling an estimated $32.7K and leaving 113 shares worth $70.5K. The position accounts for 0.03% of the portfolio, ranked #413.

AmeriFlex Group first reported a position in REGN in Q1 2025 and has held it in 4 quarters since. The position peaked at $124K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • AmeriFlex Group held 113 shares of Regeneron Pharmaceuticals worth $70.5K as of Q2 2026.
  • AmeriFlex Group sold 48 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $32.7K.
  • Regeneron Pharmaceuticals made up 0.03% of AmeriFlex Group's portfolio in Q2 2026, its #413 holding.
  • AmeriFlex Group first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • AmeriFlex Group's Regeneron Pharmaceuticals position peaked at $124K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.